Medical and Endoscopic Management of Achalasia
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
;
: 82-86, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-85475
ABSTRACT
Achalasia is a rare primary esophageal motility disorder. Because its etiology is uncertain, treatment is focused on palliation of symptoms or for decreasing lower esophageal sphincter pressure. Treatment options include pharmacological, endoscopic and surgical methods. Various medications including nitrates, calcium channel blockers, and nitric oxide donors (sildenafil) are available, but their effectiveness is inconsistent. Endoscopic options include pneumatic balloon dilation, injection of botulinum toxin, temporary self-expandable metal stent placement, and peroral endoscopic myotomy. Laparoscopic or open myotomy can be a surgical option. We reviewed the treatment options focusing on medical and endoscopic management of achalasia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Toxinas Botulínicas
/
Bloqueadores de los Canales de Calcio
/
Trastornos de la Motilidad Esofágica
/
Acalasia del Esófago
/
Stents
/
Donantes de Óxido Nítrico
/
Esfínter Esofágico Inferior
/
Nitratos
Idioma:
Coreano
Revista:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS